Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

BACKGROUND: Women with type 2 diabetes mellitus (T2DM) have a higher risk of fractures despite increased bone mineral density (BMD). In experimental studies a potential role of plasminogen activator inhibitor-1 (PAI-1) in bone remodeling is suggested but studies in humans are lacking. This is a firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Canecki-Varžić, Silvija, Prpić-Križevac, Ivana, Bilić-Ćurčić, Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778311/
https://www.ncbi.nlm.nih.gov/pubmed/26940634
http://dx.doi.org/10.1186/s12902-016-0094-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778311/
https://www.ncbi.nlm.nih.gov/pubmed/26940634
http://dx.doi.org/10.1186/s12902-016-0094-x

Ejemplares similares